RENAISSANCE TECHNOLOGIES LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1037389
NEW YORK, NY
Position in MRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,744,503
+$16,675,434 QoQ
Shares Held
4,606,491
+8.0% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#8
of 177 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. MRVI ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,744,503 | 4,606,491 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,069,069 | 4,264,689 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,731,539 | 4,225,089 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,392,915 | 4,318,089 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,088,715 | 4,186,189 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,084,622 | 4,110,689 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,648,430 | 3,972,189 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,390,727 | 4,138,475 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $27,791,117 | 3,881,441 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $27,855,747 | 3,212,889 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $18,901,262 | 2,885,689 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,596,890 | 2,659,689 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,343,805 | 2,441,175 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $44,726,925 | 3,192,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $47,608,625 | 3,326,948 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $38,874,531 | 1,522,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $53,268,750 | 1,875,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $32,208,564 | 913,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,827,120 | 544,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $46,629,975 | 950,081 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $26,907,504 | 644,800 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||